0001209191-12-042188.txt : 20120816
0001209191-12-042188.hdr.sgml : 20120816
20120816162623
ACCESSION NUMBER: 0001209191-12-042188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120814
FILED AS OF DATE: 20120816
DATE AS OF CHANGE: 20120816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INVACARE CORP
CENTRAL INDEX KEY: 0000742112
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 952680965
STATE OF INCORPORATION: OH
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE INVACARE WAY
STREET 2: P O BOX 4028
CITY: ELYRIA
STATE: OH
ZIP: 44036
BUSINESS PHONE: 4403296000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaPlaca Anthony
CENTRAL INDEX KEY: 0001453022
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15103
FILM NUMBER: 121040309
MAIL ADDRESS:
STREET 1: ONE INVACARE WAY
CITY: ELYRIA
STATE: OH
ZIP: 44035
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-08-14
0
0000742112
INVACARE CORP
IVC
0001453022
LaPlaca Anthony
ONE INVACARE WAY
ELYRIA
OH
44035
0
1
0
0
Sr. VP and General Counsel
Common Shares
2012-08-14
4
A
0
3000
0.00
A
15368
D
Employee Stock Option (Right to Buy)
13.37
2012-08-14
4
A
0
3375
0.00
A
2013-09-30
2022-08-14
Common Shares
3375
63075
D
Employee Stock Option (Right to Buy)
13.37
2012-08-14
4
A
0
3375
0.00
A
2014-09-30
2022-08-14
Common Shares
3375
66450
D
Employee Stock Option (Right to Buy)
13.37
2012-08-14
4
A
0
3375
0.00
A
2015-09-30
2022-08-14
Common Shares
3375
69825
D
Employee Stock Option (Right to Buy)
13.37
2012-08-14
4
A
0
3375
0.00
A
2016-09-30
2022-08-14
Common Shares
3375
73200
D
Restricted shares granted pursuant to the Invacare Corporation 2003 Performance Plan in an exempt transaction under Rule 16b-3. These shares vest in 25% increments over four years commencing on November 15, 2013.
The reporting person holds previously reported options to buy 59,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between October 27, 2008 and September 2, 2011, at exercise prices between $16.55 and $25.24 per share, will expire between October 27, 2018 and September 2, 2021 and became or will become exercisable between September 30, 2009 and September 30, 2015.
/s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission
2012-08-16